Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Urea 40% Salicylic Acid 2% Green Tea Leafl 1% Coconut Oil 1% Healthy Feet
Brand Name
Healmusz Healthy Feet
Generic Name
Urea 40% Salicylic Acid 2% Green Tea Leafl 1% Coconut Oil 1% Healthy Feet
Active Ingredient
Camellia Sinensis LeafCategory
Non-Standardized Chemical Allergen [EPC]
Variants
1
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 1 g/100g | CREAM | TOPICAL | 85248-067 |
Detailed information about Healmusz Healthy Feet
References used for this content
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Healmusz Healthy Feet, you must consult a qualified healthcare professional.
Camellia Sinensis Leaf is a non-standardized chemical allergen used primarily in diagnostic allergy testing and immunotherapy. It belongs to the class of allergenic extracts and is derived from the tea plant.
Dosage for Camellia Sinensis Leaf extract is highly individualized and must be determined by a specialist (Allergist/Immunologist).
Camellia Sinensis Leaf extracts may be used in children, but extreme caution is required.
No specific dosage adjustments are required for skin testing in patients with renal impairment, as systemic absorption is minimal. However, in patients with end-stage renal disease, skin reactivity may be slightly diminished (uremic pruritus/skin changes), potentially leading to false-negative results.
There are no documented dosage adjustments for hepatic impairment regarding the use of Camellia Sinensis Leaf extracts. The metabolism of small amounts of injected protein is not significantly affected by liver function.
In patients over age 65, skin reactivity to allergens often decreases. Healthcare providers may need to use intradermal testing more frequently to confirm a diagnosis. Additionally, elderly patients with pre-existing cardiovascular disease are at higher risk if a systemic reaction (anaphylaxis) occurs.
Camellia Sinensis Leaf extracts are never for self-administration. They must be administered by a trained healthcare professional in a clinical setting equipped with emergency resuscitation equipment.
If a dose of immunotherapy is missed, the patient should contact their allergist immediately.
An 'overdose' in the context of allergenic extracts refers to the administration of too much allergen, leading to a systemic reaction.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.
The most common side effects of Camellia Sinensis Leaf extract are localized to the site of administration.
> Warning: Stop taking Camellia Sinensis Leaf treatments and call your doctor immediately or seek emergency care if you experience any of these symptoms of anaphylaxis:
In the context of immunotherapy, long-term use is generally well-tolerated. However, there is a theoretical risk of:
While Camellia Sinensis Leaf is a non-standardized extract, the FDA requires a general Black Box Warning for all allergenic extracts due to the risk of severe systemic reactions.
Summary of Warning: Allergenic extracts can cause severe life-threatening systemic reactions, including anaphylaxis. These products should only be administered by healthcare professionals who are experienced in the diagnosis and treatment of allergic diseases and who are equipped to manage such reactions. Patients with unstable or severe asthma are at increased risk for life-threatening reactions. Patients should be observed for at least 30 minutes after each injection.
Report any unusual symptoms to your healthcare provider.
Camellia Sinensis Leaf extracts are potent biological materials. They are intended for use only by clinicians specialized in allergy and immunology. Patients must provide a full medical history, specifically highlighting any history of severe asthma or previous reactions to tea or other botanical extracts.
No FDA black box warnings specifically for Camellia Sinensis Leaf exist as a unique entity, but it falls under the mandatory class-wide black box warning for all Allergenic Extracts. This warning emphasizes that these extracts can cause anaphylaxis and must be administered in a medical setting with immediate access to epinephrine and airway management tools.
While the extract itself does not cause sedation, a systemic reaction or the subsequent administration of antihistamines or epinephrine can impair the ability to drive or operate machinery. Patients should ensure they feel completely normal before leaving the clinic and attempting to drive.
Alcohol consumption should be avoided for several hours before and after administration. Alcohol causes vasodilation (widening of blood vessels), which can potentially increase the rate of allergen absorption and increase the severity of a systemic reaction.
If a patient experiences a severe systemic reaction, the healthcare provider will re-evaluate the risk-benefit ratio of continuing treatment. Immunotherapy is typically discontinued if the patient fails to show clinical improvement after an adequate period (usually 12–24 months) or if the reactions to the injections are consistently severe.
> Important: Discuss all your medical conditions with your healthcare provider before starting Camellia Sinensis Leaf.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.
Patients allergic to Camellia Sinensis Leaf may show cross-reactivity with other members of the Theaceae family. There is also anecdotal evidence of cross-reactivity with certain pollens or other botanical extracts, though this is not well-standardized. Patients should inform their doctor if they have known allergies to other herbal products or specific botanical families.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Camellia Sinensis Leaf.
Camellia Sinensis Leaf extract is classified in the FDA Pregnancy Category C. This means that animal reproduction studies have not been conducted, and it is not known whether the extract can cause fetal harm. The primary risk during pregnancy is not the extract itself, but the potential for a systemic allergic reaction (anaphylaxis) in the mother. Anaphylaxis can lead to maternal hypotension, which causes decreased uterine blood flow and fetal hypoxia (oxygen deprivation), potentially resulting in fetal death or brain damage. Therefore, starting immunotherapy during pregnancy is generally avoided. If a patient is already on a stable maintenance dose and becomes pregnant, the physician may choose to continue the treatment but will not increase the dose.
It is not known whether the allergenic proteins from Camellia Sinensis Leaf extract are excreted in human milk. However, since these are large protein molecules that are typically broken down at the site of injection or in the lymphatic system, it is unlikely that significant amounts reach the breast milk. The chemical constituents like caffeine and EGCG do pass into breast milk but in very small quantities when administered as an extract. The decision to continue treatment while breastfeeding should involve a risk-benefit analysis by the healthcare provider.
Skin testing with Camellia Sinensis Leaf is considered safe in children when performed by a specialist. However, the emotional and physical stress of the procedure must be managed. For immunotherapy, the 'approved' age is generally 5 years and older. Younger children may not be able to articulate the early symptoms of a systemic reaction (such as an itchy throat or 'feeling of doom'), which can delay the administration of life-saving epinephrine.
In patients over 65, the risk of complications from a systemic reaction is significantly higher due to the increased prevalence of cardiovascular and pulmonary diseases. Elderly patients are more likely to be taking medications like beta-blockers or ACE inhibitors, which complicate the management of anaphylaxis. Furthermore, skin reactivity decreases with age, which may lead to less reliable test results. Physicians often use lower starting doses and slower 'build-up' schedules for older adults.
There is no evidence that renal impairment significantly alters the response to or the safety of Camellia Sinensis Leaf allergenic extracts. Because the proteins are metabolized locally and systemically by proteases, the kidneys do not play a primary role in clearing the active allergen. However, uremia (buildup of toxins in the blood) can suppress skin test reactivity.
Liver disease does not typically affect the safety or efficacy of allergenic extracts. The liver's role in processing these specific proteins is minimal compared to its role in metabolizing small-molecule drugs. No specific dosage adjustments are recommended for patients with hepatic impairment.
> Important: Special populations require individualized medical assessment.
Camellia Sinensis Leaf extract acts as a diagnostic and therapeutic agent by interacting with the Type I Hypersensitivity pathway.
The pharmacodynamic effect is measured by the size of the skin reaction (wheal diameter). The dose-response relationship is logarithmic; small increases in concentration can lead to significantly larger skin reactions in sensitized individuals. The duration of the skin reaction is short (1–2 hours), but the immunological changes from immunotherapy can last for years.
| Parameter | Value |
|---|---|
| Bioavailability | Negligible (Skin Test); Slow/Partial (Subcutaneous) |
| Protein Binding | N/A (Proteins are degraded rather than bound) |
| Half-life | 2–5 hours (Chemical constituents); Minutes (Proteins) |
| Tmax | 15–20 minutes (Skin reaction); 1–3 hours (Systemic absorption) |
| Metabolism | Local and Systemic Proteolysis |
| Excretion | Renal (Metabolites of polyphenols); Fecal (Minimal) |
Camellia Sinensis Leaf belongs to the Allergenic Extracts therapeutic class. It is specifically categorized as a Non-Standardized Chemical Allergen [EPC]. Related medications include other botanical extracts like Oak, Grass, or Ragweed extracts used for similar diagnostic and therapeutic purposes.
Common questions about Healmusz Healthy Feet
In a medical context, Camellia Sinensis Leaf extract is used as a diagnostic tool to identify individuals who are allergic to tea. It is administered by an allergist through skin prick or intradermal testing to observe if a 'wheal and flare' reaction occurs. In some specialized cases, it may also be used in immunotherapy to help desensitize a patient to tea allergens. It is particularly important for diagnosing occupational allergies in workers who handle tea leaves or dust. This extract is a clinical product and is different from the tea you drink at home.
The most common side effects are localized to the site where the extract was applied or injected. Patients frequently experience itching, redness, and a raised bump (wheal) at the test site, which is a normal part of the diagnostic process. Some people may also experience mild swelling or a 'heavy' feeling in the arm after an immunotherapy injection. These local reactions usually disappear within a few hours to a couple of days. However, any reaction that spreads beyond the local area should be reported to a doctor immediately.
It is strongly advised to avoid alcohol consumption on the day of your allergy testing or immunotherapy injection. Alcohol acts as a vasodilator, meaning it widens your blood vessels and increases blood flow to the skin. This can potentially make a local allergic reaction larger or, more seriously, speed up the absorption of the allergen into your bloodstream, increasing the risk of a systemic reaction (anaphylaxis). Always follow the specific 'pre-test' instructions provided by your allergy clinic. Discuss your alcohol use with your healthcare provider to ensure your safety.
The use of Camellia Sinensis Leaf extract during pregnancy is generally approached with extreme caution. While the extract itself is not known to be a toxin or teratogen, the risk of a systemic allergic reaction (anaphylaxis) poses a significant danger to the fetus. Anaphylaxis in the mother can lead to a sudden drop in blood pressure, which reduces the oxygen supply to the baby. Most doctors will not start new allergy testing or immunotherapy during pregnancy. If you are already on a maintenance dose, your doctor may continue it but will likely not increase the dosage.
For diagnostic purposes, Camellia Sinensis Leaf extract works very quickly, with results appearing within 15 to 20 minutes of the skin test. For therapeutic purposes, such as immunotherapy, the process is much slower. It typically takes 3 to 6 months of weekly injections (the build-up phase) before you reach a maintenance dose. Significant improvement in allergy symptoms usually isn't noticed until the patient has been on the maintenance dose for several months. Most patients require 3 to 5 years of treatment for long-term benefits.
If you are undergoing diagnostic testing, there is no 'stopping' as it is a one-time procedure. However, if you are receiving immunotherapy injections, you can stop the treatment at any time, but you must inform your doctor. Stopping suddenly will not cause 'withdrawal' symptoms like some medications do, but your allergy symptoms will likely return to their previous severity. If you miss several doses and then try to restart at the same high dose, you may be at a higher risk for a severe allergic reaction. Always consult your allergist before changing your treatment schedule.
If you miss a scheduled immunotherapy injection of Camellia Sinensis Leaf, contact your allergist's office as soon as possible to reschedule. Do not attempt to 'double up' on your next dose. Depending on how much time has passed since your last injection, your doctor may need to reduce the dose for your next visit to ensure your safety. If too much time passes (usually more than 4 weeks), you may need to restart a portion of the build-up phase. Consistency is key to both the safety and effectiveness of allergen immunotherapy.
There is no clinical evidence to suggest that Camellia Sinensis Leaf extract, when used for allergy testing or immunotherapy, causes weight gain. The amount of extract used is extremely small and does not have the systemic metabolic effects associated with weight changes. While oral consumption of green tea is sometimes marketed for weight loss due to its caffeine and catechin content, the clinical extract used in allergy medicine is not used for this purpose. If you experience unexplained weight gain, you should discuss it with your primary care physician to find the underlying cause.
Camellia Sinensis Leaf extract can interact with several types of medications, particularly those that affect your heart or immune system. Antihistamines must be stopped before testing because they block the very reaction the doctor is looking for. More importantly, medications like beta-blockers and ACE inhibitors can make an allergic reaction more dangerous or harder to treat. You must provide your doctor with a complete list of all prescriptions, over-the-counter drugs, and herbal supplements you are taking. Your doctor will determine if any of these medications need to be adjusted before your procedure.
Allergenic extracts like Camellia Sinensis Leaf are biological products rather than standard chemical drugs, so the term 'generic' is not used in the same way. However, various manufacturers produce 'non-standardized' tea leaf extracts. While these extracts all contain the same basic botanical material, they may differ slightly in their concentration or the way they are processed. Your allergist will typically use a consistent supplier to ensure that your dosage remains stable throughout your testing or treatment. These products are not available over-the-counter and must be ordered by a licensed healthcare professional.
Other drugs with the same active ingredient (Camellia Sinensis Leaf)